Sodium valproate: cacosmia and dysgeusia as uncommon side effects

Clara Montalbano, Accursio Raia, Valerio Caruso, Lavinia Migli

Abstract


Smell and taste disturbances are potential adverse reactions of many drugs used in Psychiatry, such as antidepressants, anti-Parkinson agents, lithium, minor and major tranquilizers. To our knowledge, only one clinical case regarding valproate and cacosmia has been reported so far. However, several anticonvulsants are reported to cause taste and smell disturbances, although the underlying etiology is currently unclear. Our patient developed cacosmia and dysgeusia when taking valproic acid, both effects quickly disappeared upon drug discontinuation. In this article we not only report this uncommon side effect, but we discuss the plausible mechanisms behind such an adverse reaction. Our case is to date the second similar case in the literature. The aim of the present article is to make clinicians informed about this very uncommon and unpleasant side effect.

Keywords


bipolar; valproate; smell; cacosmia; dysgeusia

Full Text:

PDF

References


Doty RL, Shah M, Bromley SM. Drug-induced taste disorders. Drug Saf. 2008;31(3):199-215. doi: 10.2165/00002018-200831030-00002. PMID: 18302445.

Naik BS, Shetty N, Maben EV. Drug-induced taste disorders. Eur J Intern Med. 2010;21(3):240-3. doi: 10.1016/j.ejim.2010.01.017. PMID: 20493431.

Tomita H, Yoshikawa T. Drug-related taste disturbances. Acta Otolaryngol Suppl. 2002;(546):116-21. doi: 10.1080/00016480260046490. PMID: 12132608.

Kishi T, Ikuta T, Matsuda Y, et al. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Mol Psychiatry. 2022;27(2):1136-1144. doi: 10.1038/s41380-021-01334-4. PMID: 34642461; PMCID: PMC9054678.

Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013;46(15):1323-38. doi: 10.1016/j.clinbiochem.2013.06.012. PMID: 23792104.

Alvarez P, Papaseit E, Pérez V, Bulbena A, Farré M. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report. Actas Esp Psiquiatr. 2019;47(1):33-6. PMID: 30724329.

Baumann CR, Ott PM, Siegel AM. Hypogeusia as an adverse reaction of phenytoin. Br J Clin Pharmacol. 2004;58(6):678-9. doi: 10.1111/j.1365-2125.2004.02217.x. PMID: 15563368; PMCID: PMC1884645.

Avoni P, Contin M, Riva R, et al. Dysgeusia in epileptic patients treated with lamotrigine: report of three cases. Neurology. 2001;57(8):1521. doi: 10.1212/wnl.57.8.1521. PMID: 11673609.

Ghanizadeh A. Loss of taste and smell during treatment with topiramate. Eat Weight Disord. 2009;14(2-3):e137-8. doi: 10.1007/BF03327811. PMID: 19934627.

Rollin H. Drug-related gustatory disorders. Ann Otol Rhinol Laryngol. 1978;87(1 Pt 1):37-42. doi: 10.1177/000348947808700108. PMID: 623418.

Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol. 1992;32(3):386-92. doi: 10.1002/ana.410320313. PMID: 1416808.

Thiermann F, Buchbauer G. Influence of drugs on smelling capacity. A review. Flavour Fragr J. 2017; 32:147–158. doi: 10.1002/ffj.3368

Abbott FS, Burton R, Orr J, et al. Valproic acid analysis in saliva and serum using selected ion monitoring (electron ionization) of the tert.-butyldimethylsilyl derivatives. J Chromatogr. 1982;227(2):433-44. doi: 10.1016/s0378-4347(00)80396-5. PMID: 6801067.

Bertolino M, Acerbi D, Canali S, et al. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester. Eur J Drug Metab Pharmacokinet. 1998;23(2):223-9. doi: 10.1007/BF03189344. PMID: 9725486.

Gao N, Lu M, Echeverri F, et al. Voltage-gated sodium channels in taste bud cells. BMC Neurosci. 2009;10:20. doi: 10.1186/1471-2202-10-20. PMID: 19284629; PMCID: PMC2660338.

Erikssen J, Seegaard E, Naess K. Letter: Side-effect of thiocarbamides. Lancet. 1975;1(7900):231-2. doi: 10.1016/s0140-6736(75)91417-8. PMID: 47475.

Henkin RI, Bradley DF. Hypogeusia corrected by Ni++ and Zn++. Life Sci II. 1970;9(12):701-9. doi: 10.1016/0024-3205(70)90278-x. PMID: 5478084.

Korkmazer N, Vurucu S, Demirkaya E, et al. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev. 2006;28(8):515-20. doi: 10.1016/j.braindev.2006.03.003. PMID: 16682156.

Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol. 2009;13(5):439-43. doi: 10.1016/j.ejpn.2008.08.007. PMID: 18922714.

Shinkai RS, Hatch JP, Schmidt CB, Sartori EA. Exposure to the oral side effects of medication in a community-based sample. Spec Care Dentist. 2006;26(3):116-20. doi: 10.1111/j.1754-4505.2006.tb01434.x. PMID: 16774189.




Copyright (c) 2023 Clara Montalbano

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

ISSN: 2360-6975